Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF REFACTO AF IN PREVIOUSLY UNTREATED PATIENTS IN USUAL CARE SETTINGS

NCT00950170 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00950170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00950170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF REFACTO AF IN PREVIOUSLY UNTREATED PATIENTS IN USUAL CARE SETTINGS
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
February 10, 2010
Completion date
November 24, 2016
Enrollment
23 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a